Zydus receives USFDA approval for a surgical imaging drug, Indocyanine Green, with a 180-day exclusivity window for marketing.
SENSEX 78,428.95
NIFTY 24,614.90
CRUDEOIL 7,806.00
+ 161.00
GOLD 141,949.00
Zydus and Apollo Hospitals collaborate to enhance access to a multi-cancer blood test for early detection in India.
Granules India achieves First-to-File status for generic Lumryz tablets in the US, enhancing its position in complex generics.
The recent rally in the stock followed the USFDA’s approval for Zaynich (cefepime and zidebactam), an intravenous antibiotic for…
Cipla’s Goa facility receives VAI classification from US FDA after April inspection, indicating no regulatory or enforcement…
The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty drugs…
GVRP and StepsBio establish a Bengaluru CoE for advanced formulations R&D, enhancing drug delivery systems and sterile…
